EP3513804
FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.7.2012EP published:
23.3.2022EP application number:
18211156.7
EPO information:
European Patent Register
Max expiry date:
5.7.2032
Title in English:
FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
6.7.2012EP application
23.3.2022EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451, US
Inventor
Name:
DUMONT, Jennifer A.Address:
Groton, MA Massachusetts 01450, US
Name:
LOW, SusanAddress:
Pepperill, MA Massachusetts 01463, US
Name:
BITONTI, Alan, J.Address:
Acton, MA Massachusetts 01720, US
Name:
PIERCE, GlennAddress:
Rancho Santa Fe, CA California 92067, US
Name:
LUK, AlvinAddress:
Boston, MA Massachusetts 02114-1897, US
Name:
JIANG, HaiyanAddress:
Belmont, MA Massachusetts 02478, US
Name:
MCKINNEY, ByronAddress:
San Diego, CA California 92122, US
Name:
OTTMER, MattAddress:
Newton, MA Massachusetts 02459, US
Name:
SOMMER, JurgAddress:
Wayland, MA Massachusetts 01778, US
Name:
NUGENT, KarenAddress:
Princes Risborough, Buckinghamshire HP27 9RH, GB
Name:
LI, LianAddress:
Lexington, MA Massachusetts 02420, US
Name:
PETERS, RobertAddress:
West Roxbury, MA Massachusetts 02132, US
Priority
Number:
201161506015 PDate:
8.7.2011Country:
US
Number:
201161522647 PDate:
11.8.2011Country:
US
Number:
201161541561 PDate:
30.9.2011Country:
US
Number:
201161569158 PDate:
9.12.2011Country:
US
Number:
201261586443 PDate:
13.1.2012Country:
US
Number:
201261622789 PDate:
11.4.2012Country:
US
Number:
201261657641 PDate:
8.6.2012Country:
US
Classification
Categories:
A61K 38/37, C07K 14/755, A61K 47/60, A61K 47/68, G01N 33/86, A61P 7/02, A61P 43/00